Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab

L. J. Addonizio, Robert E. Michler, C. Marboe, P. E. Esser, L. L. Johnson, D. W. Seldin, W. M. Gersony, P. O. Alderson, E. A. Rose, P. J. Cannon

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The acute rejection of cardiac allografts is currently diagnosed by the presence of myocyte necrosis on endomyocardial biopsy. We evaluated the efficacy of noninvasive scintigraphic imaging with indium-111-labeled anticardiac myosin Fab fragments (indium-111 antimyosin) to detect and quantify cardiac allograft rejection. Six dogs that had intrathoracic heterotopic cardiac allograft transplantation were injected with indium-111 antimyosin and planar and single photon emission computed tomographic (SPECT) images were obtained in various stages of acute and subacute rejection. Four dogs had an allograft older than 8 months and had been on long-term immunosuppressive therapy; two dogs had an allograft less than 2 weeks old and were not on immunosuppressive therapy. Count ratios comparing heterotopic with native hearts were calculated from both SPECT images and in vitro scans of excised and sectioned hearts and were compared with the degree of rejection scored by an independent histopathologic review. Indium-111 antimyosin uptake was not visible in planar or SPECT images of native hearts. Faint diffuse uptake was apparent in cardiac allografts during long-term immunosuppression and intense radioactivity was present in hearts with electrocardiographic evidence of rejection. The heterotopic to native heart count ratios in SPECT images correlated significantly with the count ratios in the excised hearts (r = 0.93) and with the histopathologic rejection score (r = 0.97). The distribution of indium-111 antimyosin activity in right and left ventricles corresponded to areas of histopathologic abnormalities. Immunoperoxidase studies showed deposition of indium-111 antimyosin only in areas of myocyte necrosis. The results demonstrate that indium-111 antimyosin imaging can noninvasively detect the presence, location and severity of canine cardiac allograft rejection.

Original languageEnglish (US)
Pages (from-to)555-564
Number of pages10
JournalJournal of the American College of Cardiology
Volume9
Issue number3
StatePublished - 1987
Externally publishedYes

Fingerprint

Allografts
Dogs
Photons
Immunosuppressive Agents
Muscle Cells
Heart Ventricles
Necrosis
Heterotopic Transplantation
Immunoglobulin Fab Fragments
Indium
Heart Transplantation
Myosins
imciromab pentetate
Immunosuppression
Radioactivity
Canidae
Biopsy
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Addonizio, L. J., Michler, R. E., Marboe, C., Esser, P. E., Johnson, L. L., Seldin, D. W., ... Cannon, P. J. (1987). Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. Journal of the American College of Cardiology, 9(3), 555-564.

Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. / Addonizio, L. J.; Michler, Robert E.; Marboe, C.; Esser, P. E.; Johnson, L. L.; Seldin, D. W.; Gersony, W. M.; Alderson, P. O.; Rose, E. A.; Cannon, P. J.

In: Journal of the American College of Cardiology, Vol. 9, No. 3, 1987, p. 555-564.

Research output: Contribution to journalArticle

Addonizio, LJ, Michler, RE, Marboe, C, Esser, PE, Johnson, LL, Seldin, DW, Gersony, WM, Alderson, PO, Rose, EA & Cannon, PJ 1987, 'Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab', Journal of the American College of Cardiology, vol. 9, no. 3, pp. 555-564.
Addonizio, L. J. ; Michler, Robert E. ; Marboe, C. ; Esser, P. E. ; Johnson, L. L. ; Seldin, D. W. ; Gersony, W. M. ; Alderson, P. O. ; Rose, E. A. ; Cannon, P. J. / Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. In: Journal of the American College of Cardiology. 1987 ; Vol. 9, No. 3. pp. 555-564.
@article{a5de3684714848d6b0aa862eae2d1f73,
title = "Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab",
abstract = "The acute rejection of cardiac allografts is currently diagnosed by the presence of myocyte necrosis on endomyocardial biopsy. We evaluated the efficacy of noninvasive scintigraphic imaging with indium-111-labeled anticardiac myosin Fab fragments (indium-111 antimyosin) to detect and quantify cardiac allograft rejection. Six dogs that had intrathoracic heterotopic cardiac allograft transplantation were injected with indium-111 antimyosin and planar and single photon emission computed tomographic (SPECT) images were obtained in various stages of acute and subacute rejection. Four dogs had an allograft older than 8 months and had been on long-term immunosuppressive therapy; two dogs had an allograft less than 2 weeks old and were not on immunosuppressive therapy. Count ratios comparing heterotopic with native hearts were calculated from both SPECT images and in vitro scans of excised and sectioned hearts and were compared with the degree of rejection scored by an independent histopathologic review. Indium-111 antimyosin uptake was not visible in planar or SPECT images of native hearts. Faint diffuse uptake was apparent in cardiac allografts during long-term immunosuppression and intense radioactivity was present in hearts with electrocardiographic evidence of rejection. The heterotopic to native heart count ratios in SPECT images correlated significantly with the count ratios in the excised hearts (r = 0.93) and with the histopathologic rejection score (r = 0.97). The distribution of indium-111 antimyosin activity in right and left ventricles corresponded to areas of histopathologic abnormalities. Immunoperoxidase studies showed deposition of indium-111 antimyosin only in areas of myocyte necrosis. The results demonstrate that indium-111 antimyosin imaging can noninvasively detect the presence, location and severity of canine cardiac allograft rejection.",
author = "Addonizio, {L. J.} and Michler, {Robert E.} and C. Marboe and Esser, {P. E.} and Johnson, {L. L.} and Seldin, {D. W.} and Gersony, {W. M.} and Alderson, {P. O.} and Rose, {E. A.} and Cannon, {P. J.}",
year = "1987",
language = "English (US)",
volume = "9",
pages = "555--564",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab

AU - Addonizio, L. J.

AU - Michler, Robert E.

AU - Marboe, C.

AU - Esser, P. E.

AU - Johnson, L. L.

AU - Seldin, D. W.

AU - Gersony, W. M.

AU - Alderson, P. O.

AU - Rose, E. A.

AU - Cannon, P. J.

PY - 1987

Y1 - 1987

N2 - The acute rejection of cardiac allografts is currently diagnosed by the presence of myocyte necrosis on endomyocardial biopsy. We evaluated the efficacy of noninvasive scintigraphic imaging with indium-111-labeled anticardiac myosin Fab fragments (indium-111 antimyosin) to detect and quantify cardiac allograft rejection. Six dogs that had intrathoracic heterotopic cardiac allograft transplantation were injected with indium-111 antimyosin and planar and single photon emission computed tomographic (SPECT) images were obtained in various stages of acute and subacute rejection. Four dogs had an allograft older than 8 months and had been on long-term immunosuppressive therapy; two dogs had an allograft less than 2 weeks old and were not on immunosuppressive therapy. Count ratios comparing heterotopic with native hearts were calculated from both SPECT images and in vitro scans of excised and sectioned hearts and were compared with the degree of rejection scored by an independent histopathologic review. Indium-111 antimyosin uptake was not visible in planar or SPECT images of native hearts. Faint diffuse uptake was apparent in cardiac allografts during long-term immunosuppression and intense radioactivity was present in hearts with electrocardiographic evidence of rejection. The heterotopic to native heart count ratios in SPECT images correlated significantly with the count ratios in the excised hearts (r = 0.93) and with the histopathologic rejection score (r = 0.97). The distribution of indium-111 antimyosin activity in right and left ventricles corresponded to areas of histopathologic abnormalities. Immunoperoxidase studies showed deposition of indium-111 antimyosin only in areas of myocyte necrosis. The results demonstrate that indium-111 antimyosin imaging can noninvasively detect the presence, location and severity of canine cardiac allograft rejection.

AB - The acute rejection of cardiac allografts is currently diagnosed by the presence of myocyte necrosis on endomyocardial biopsy. We evaluated the efficacy of noninvasive scintigraphic imaging with indium-111-labeled anticardiac myosin Fab fragments (indium-111 antimyosin) to detect and quantify cardiac allograft rejection. Six dogs that had intrathoracic heterotopic cardiac allograft transplantation were injected with indium-111 antimyosin and planar and single photon emission computed tomographic (SPECT) images were obtained in various stages of acute and subacute rejection. Four dogs had an allograft older than 8 months and had been on long-term immunosuppressive therapy; two dogs had an allograft less than 2 weeks old and were not on immunosuppressive therapy. Count ratios comparing heterotopic with native hearts were calculated from both SPECT images and in vitro scans of excised and sectioned hearts and were compared with the degree of rejection scored by an independent histopathologic review. Indium-111 antimyosin uptake was not visible in planar or SPECT images of native hearts. Faint diffuse uptake was apparent in cardiac allografts during long-term immunosuppression and intense radioactivity was present in hearts with electrocardiographic evidence of rejection. The heterotopic to native heart count ratios in SPECT images correlated significantly with the count ratios in the excised hearts (r = 0.93) and with the histopathologic rejection score (r = 0.97). The distribution of indium-111 antimyosin activity in right and left ventricles corresponded to areas of histopathologic abnormalities. Immunoperoxidase studies showed deposition of indium-111 antimyosin only in areas of myocyte necrosis. The results demonstrate that indium-111 antimyosin imaging can noninvasively detect the presence, location and severity of canine cardiac allograft rejection.

UR - http://www.scopus.com/inward/record.url?scp=0023152972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023152972&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 555

EP - 564

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 3

ER -